These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28766540)
1. [Leukemization of follicular lymphoma: The features of diagnostic and clinical course of a rare form of the disease]. Nesterova ES; Kravchenko SK; Mangasarova YK; Plastinina LV; Dvirnyk VN; Kovrigina AM; Shchupletsova IA; Obukhova TN; Gemdzhian EG; Vorobyev IA; Vorobyev AI Ter Arkh; 2017; 89(7):45-50. PubMed ID: 28766540 [TBL] [Abstract][Full Text] [Related]
2. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia]. Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617 [TBL] [Abstract][Full Text] [Related]
3. [Follicular lymphoma: first - line selection criteria of treatment]. Nesterova ES; Kravchenko SK; Kovrigina AM; Gemdzhian EG; Plastinina LV; Babaeva FE; Obukhova TN; Magomedova AU; Gaponova TV; Kremenetskaya AM; Vorobyev AI Ter Arkh; 2019 Aug; 91(8):75-83. PubMed ID: 32598757 [TBL] [Abstract][Full Text] [Related]
4. Follicular lymphoma: 2012 update on diagnosis and management. Freedman A Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911 [TBL] [Abstract][Full Text] [Related]
5. [Comparison between CHOP-like and R-CHOP in diffuse large B cell and follicular lymphoma]. Oliver C; Guillermo C; Martínez P; Díaz L Rev Med Chil; 2013 Jul; 141(7):844-52. PubMed ID: 24356732 [TBL] [Abstract][Full Text] [Related]
6. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group. Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255 [TBL] [Abstract][Full Text] [Related]
9. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study. Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156 [TBL] [Abstract][Full Text] [Related]
10. Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma. Kwon J; Kim IH; Kim BH; Kim TM; Heo DS Int J Radiat Oncol Biol Phys; 2015 May; 92(1):91-8. PubMed ID: 25721091 [TBL] [Abstract][Full Text] [Related]
11. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911. Press OW; Unger JM; Braziel RM; Maloney DG; Miller TP; Leblanc M; Fisher RI; J Clin Oncol; 2006 Sep; 24(25):4143-9. PubMed ID: 16896003 [TBL] [Abstract][Full Text] [Related]
14. The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Andresen S; Brandt J; Dietrich S; Memmer ML; Ho AD; Witzens-Harig M Leuk Lymphoma; 2012 Mar; 53(3):386-93. PubMed ID: 21864036 [TBL] [Abstract][Full Text] [Related]
15. Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG. Binkley MS; Brady JL; Hajj C; Chelius M; Chau K; Balogh A; Levis M; Filippi AR; Jones M; Ahmed S; MacManus M; Wirth A; Oguchi M; Vistisen AK; Andraos TY; Ng AK; Aleman BMP; Choi SH; Kirova YM; Hardy S; Reinartz G; Eich HT; Bratman SV; Constine LS; Suh CO; Dabaja B; El-Galaly TC; Hodgson DC; Ricardi U; Yahalom J; Mikhaeel NG; Hoppe RT Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):522-529. PubMed ID: 30858143 [TBL] [Abstract][Full Text] [Related]
16. R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi. Federico M; Luminari S; Dondi A; Tucci A; Vitolo U; Rigacci L; Di Raimondo F; Carella AM; Pulsoni A; Merli F; Arcaini L; Angrilli F; Stelitano C; Gaidano G; Dell'olio M; Marcheselli L; Franco V; Galimberti S; Sacchi S; Brugiatelli M J Clin Oncol; 2013 Apr; 31(12):1506-13. PubMed ID: 23530110 [TBL] [Abstract][Full Text] [Related]
17. Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study. Mondello P; Steiner N; Willenbacher W; Wasle I; Zaja F; Zambello R; Visentin A; Mauro E; Ferrero S; Ghione P; Pitini V; Cuzzocrea S; Mian M Ann Hematol; 2016 Jun; 95(7):1107-14. PubMed ID: 27103007 [TBL] [Abstract][Full Text] [Related]
18. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients. Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272 [TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma. Arcaini L; Morello L; Tucci A; Rusconi C; Ladetto M; Rattotti S; Bonfichi M; Bottelli C; Gabutti C; Bernasconi P; Varettoni M; Gotti M; Troletti D; Guerrera ML; Fiaccadori V; Sciarra R; Ferretti VV; Alessandrino EP; Rossi G; Morra E Am J Hematol; 2015 Mar; 90(3):230-4. PubMed ID: 25502635 [TBL] [Abstract][Full Text] [Related]
20. Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life. Sortais C; Lok A; Tessoulin B; Gastinne T; Mahé B; Dubruille V; Blin N; Touzeau C; Moreau A; Bossard C; Peterlin P; Garnier A; Guillaume T; Le Bourgeois A; Chevallier P; Moreau P; Leux C; Le Gouill S Ann Hematol; 2020 Jul; 99(7):1595-1604. PubMed ID: 32417940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]